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Abstract 
Background: The purpose of this study is to evaluate the suitability of lobectomy with 
isthmusectomy (LwI) in treatment of Follicular Thyroid Neoplasms (FTN), considering 
malignancy incidence and postoperative complications. 
Methods: 192 patients (165 females; 27 males) who underwent LwI for FTN from 01/2005 to 
12/2007 were retrospectively evaluated: clinical and pathological features, surgical 
complications and five year outcome of the remnant lobe. Inclusion criteria were cytological 
Bethesda category III and IV or histological follicular architecture. Patients with metastatic 
follicular carcinoma or previous thyroid surgery were excluded.  
Results: Mean age was 48,68±14,93yrs. Overall malignancy occurred in 88 patients (45,83%) 
and 80 (41,67%) underwent thyroidectomy completion (TC), mainly by index lesion’s 
malignancy. Forty-one (21,35%) in LwI and 31 (38,75%) in TC specimens had associated 
malignancy, mainly papillary microcarcinomas. High preoperative Thyroid-Stimulating 
Hormone (TSH), histological multinodularity and, in cytology category IV, younger age, 
were significantly associated to malignancy. Permanent recurrent laryngeal nerve lesion 
occurred in 0,58% in Lwl  and 1,52% in TC, and temporary dysphonia occurred in 9,25% and 
6,06% (LwI and TC respectively). No LwI patients presented hypoparathyroidism and 3,03% 
in TC had temporary symptoms. In LwI, 36,70% developed hypothyroidism. Higher 
preoperative TSH was associated with hypothyroidism development.  
Conclusions: LwI was inappropriate in 40,10% patients with malignancy who required TC 
and 23,12% had no functional benefit because post-LwI hypothyroidism. Nodular relapse was 
reported in at least 23/113 LwI patients (20,35%). We propose total thyroidectomy for 
patients with FTN preoperative TSH higher than 2,16 mU/L and, in Bethesda category IV, 
less than 39,5yrs. 
Key words: thyroid gland, thyroidectomy, follicular neoplasm, thyroid neoplasms, thyroid 
adenoma, Follicular Thyroid Carcinomas, complications, Fine-Needle Aspiration Biopsy, 
thyroid lobectomy, hemithyroidectomy.  
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Introduction 
Thyroid differentiated cancer is the most common endocrine neoplasia and stands for 90% of 
thyroid cancers. Its incidence has increased in western world but its mortality has remained 
constant, suggesting a better diagnostic accuracy [1, 2]. Thyroid tumors present as nodular 
lesions which are highly prevalent. On physical examination, thyroid nodules are identified in 
10% of patients and, by ultrasonography, there are reports of 67% [3]. However, only 5-30% 
of these are malignant [4]. With widespread use of Fine-Needle Aspiration Biopsy (FNAB), 
thyroid surgery for benign pathology has declined significantly. Despite a sensitivity of 83%, 
specificity of 92% and a accuracy of 95% [5], there is a “gray-zone” on FNAB which 
corresponds to Follicular Thyroid Neoplasms (FTN) whose uncertain nature requires 
histological evaluation [6]. FTN on FNAB can occur in nodular goiter, follicular adenoma 
(FA) as well as in well differentiated carcinomas (follicular carcinoma (FC) and follicular 
variant of papillary thyroid carcinoma (FVPTC)). The Bethesda System for reporting thyroid 
cytopathology has an implied risk of malignancy in category III of 5-15% and category IV of 
15-30 % [7]. When FNAB revels a FTN, final diagnosis of FC depends on histological 
demonstration of capsular and/or vascular invasion; definitive diagnosis of FVPTC depends 
on a cytological evaluation with a better sample and/or histological diagnosis for nuclear 
atypia [8, 9]. Advances in molecular genetics have tried to define specific mutations for each 
FTN. RAS mutations and t(2,3) PAX8-PPAR-gama have been found in FTN  however each 
mutation was found in the different FTN with similar frequencies [10, 11] and a study on 
genetic testing in indeterminate FNAB reported a sensitivity of 12%, specificity of 98%,  a 
positive and negative predictive value of 38% and 65%, respectively [12]. So, despite several 
clinical, imaging and molecular features being associated with FTN nature, their role in 
therapeutic decision is yet limited, even when combined, which makes Lobectomy with 
Isthmusectomy (LwI) the most accurate diagnostic procedure. Preoperative characterization 
of FTN in a lesser invasive approach remains a challenge in endocrine pathology and a 
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significant controversy also remains in the definition of the best therapeutic approach [13, 
14]. LwI is the minimal therapeutic procedure for patients with FTN, which has been 
accepted, since FTN are usually unifocal and malignancy risk is lesser than 30%. Patients 
who underwent LwI for FTN, had cancer in 19% and this procedure was considered adequate 
in 96% of patients [15], with comparable results to total thyroidectomy (TT) concerning 
recurrence and survival [16]. In more advanced neoplasms than T1N0M0, LwI had a 2,5-fold 
higher recurrence risk and 2,2-fold risk of death compared with TT [17], despite a lesser 
complications’ rate [18, 19]. TT has a higher risk of permanent hypoparathyroidism and 
recurrent laryngeal nerve palsy and all patients develop hypothyroidism requiring lifelong 
opotheraphy. In LwI, opotheraphy will be required in at least 10,9% of patients, with 1 out of 
25 patients developing clinical hypothyroidism [20, 21]. LwI can cure patients with FA and 
minimally invasive FC. It has minimal risk of hypoparathyroidism and a lower morbidity than 
TT. Patients with FC (widely invasive or angioinvasive) or FVPTC, ultimately will need a 
thyroidectomy completion (TC). 
The aim of the present study is to evaluate the incidence of malignancy in patients with FTN 
who underwent LwI, morbidity of procedure, need for TC, late post-operative hypothyroidism 
and recurrent nodular disease. 
 
Patients and methods 
A retrospective study was carried out based on clinical files of patients who underwent LwI 
for FTN or follicular lesion of undetermined significance between January 2005 and 
December 2007 in Hospital de São João, Porto, Portugal, after approval by Ethical 
Commission Boarder. Inclusion criteria were lesions with cytological Bethesda category III 
and IV or histological FTN (FA, FC, FVPTC), independently of FNAB cytology. Patients 
with metastatic FC or previous thyroid surgery were excluded. All surgeries were performed 
in our center. FNAB diagnosis was made in our center and outside. The clinical, FNAB, 
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surgical and pathological reports and follow-up during 5yrs after surgery were analyzed. The 
clinical data evaluated were age, gender, cervical palpable mass and its location, symptoms of 
cervical compression (hoarseness, dysphagia, dyspneia and cervical discomfort), 
thyrotoxicosis and familial history of thyroid malignancy. FNAB were reclassified according 
to thyroid cytopathology Bethesda System. Surgical data included LwI specimen weight and 
surgical complications (definitive recurrent laryngeal nerve lesion, temporary dysphonia, 
hypoparathyroidism, hematoma/hemorrhage, abscess formation and keloid scar). 
Hypothyroidism in LwI group during 5yrs follow-up was also considered a complication. We 
also evaluated the reasons for TC. TC weight was recorded and complications were analyzed 
as previously mentioned to LwI patients. Pathological features review focused on 
macroscopic aspect (capsulated or non-capsulated), size, uni or multinodular disease, the main 
histological diagnosis and associated lesions, the histological FC invasiveness and 
angio-invasiveness, tumor margins and thyroiditis. Outcome at five years after surgery 
included: thyroid nodular relapse, hypothyroidism in LwI group, recurrence of malignant 
pathology (locally or at distance), and death related to thyroid pathology.  
Statistical analysis   
In few patients’ records there was missing information about some of the cited topics, so 
obtained percentages have as denominator the population with valid information. Continuous 
variables with normal distribution were expressed in means with standard deviation and were 
compared through independent t-Student test. Those that had not a normal distribution were 
expressed in medians with interquartile ranges (IQR) and were compared with Mann-Whitney 
U-test. Categorical variables were presented as frequency and percentage. They were 
compared through a Pearson chi-square test or Fisher exact test. A p value ≤ 0,05 was 
considered significant. ROC curves were employed to define the best sensitivity and 
specificity cutoff points concerning age and Thyroid-Stimulating Hormone (TSH) as 
predictors of malignancy (it was intended a cutoff point with a specificity of at least 80%). All 
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statistical analyses were obtained through Statistical Package for Social Science, version 20.0 
(SPSS
®
 IBM Corporation).  
 
Results 
A total of 192 patients were included in this study, 165 females (85,94%) and 27 males 
(14,06%). The mean age at diagnosis was 48,61 years ± 14,93 (range 14-80). Nodule occurred 
on the right lobe in 57,37% patients, and was palpable 76,87%. Compressive symptoms were 
reported in 33,65% patients. LwI median weight was 13,00g (IQR 12,00g, range 
3,50-111,00g). A histological solitary nodule was reported in 118 patients (61,46%) while 74 
(38,54%) had multiple nodular lesions. Nodule size was not registered in 4 patients. The 
remaining 188 patients had a median histological nodule size of 1,70 cm (IQR 1,70 cm); 33 
patients (17,55%) had an less than 1 centimeter nodule,  71 patients (37,77%) with 1-1,9 cm 
nodule, 60 patients (31,91%) 2-3,9cm nodule and in 24 (12,77%) being ≥ 4 cm.  
All patients underwent LwI and 80 (41,67%) required a TC with median time to completion 
surgery being 96 days (IQR 52; range 15-1434). TC were required by index lesion’s 
malignancy (77 patients [40,10%]), a benign index lesion associated malignant diagnosis (2 
patients [1,04%]) and by nodular benign relapse in 1 patient (0,52%) with benign index 
lesion. TC weight median was 7,15g (IQR 4,00g, range 1,00-24,00g). Pathological analysis is 
explained on table 1. Excluding microcarcinomas, 75 (39,06%) of index lesions were 
malignant. Surgical margins in malignant lesions were classified as R0 in 68 out of 73 
patients (93,15%) and R1 in 5 (6,85%). Vascular invasion was found in 12 out of 75 
carcinomas (16,00%). All patients with R1 borders and/or vascular invasion underwent TC. 
Thyroiditis identified was in 97 out of 180 patients (53,89%). Histological evaluation from 
TC specimen was “normal” in 19 patients (23,75%), benign in 30 (37,50%) and malignant in 
31 (38,75%) – 22 (27,50%) being microcarcinomas. In the 192 patients, concerning other 
diagnosis besides index lesion in LwI and TC specimens, 48 (25,00%) presented an incidental 
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papillary microcarcinomas (30 in LwI and 22 in TC specimen – in 4 patients it was detected 
in LwI and in TC specimens). TSH pre-surgical value was higher in patients with malignant 
diagnosis (median in malignant 1,50, IQR 0,10; median in benign 1,30, IQR 1,19; p=0,027), 
with malignancy being less frequent in patients with thyrotoxicosis (p=0,015). Histological 
multinodular pathology was significantly associated with malignancy (p=0,001). It was not 
found a statistical significant difference concerning all others clinical and pathological 
features evaluated. Patients FNAB re-classification is listed on table 2. Excluding 
microcarcinomas in index nodule, 23,08% from Bethesda category III and 33,33% from 
category IV were malignant. There was not a significant difference between Bethesda 
categories III or IV and malignancy. In patients with Bethesda category IV, a malignant 
diagnosis was more frequent at lower age (mean benign 51,81 yrs ±13,66; mean malign 44,72 
yrs ± 15,92; p=0,016) and higher pre-operative TSH (median in benign 1,19, IQR 0,86; 
median in malign 1,56, IQR 1,45; p=0,045). No statistical significant difference was found 
regarding all others clinical and pathological features evaluated. In patients with Bethesda 
category III, older age was associated with malignancy (mean benign 44,94 yrs ± 11,03; mean 
malign 61,78 yrs ± 12,43; p=0,002). No statistical significant difference was found 
concerning all others clinical and pathological features evaluated.  
An TSH pre-operatory value higher than 2,16 mU/L (sensitivity 28,60%; specificity 79,7%; 
Area Under the Curve [AUC] 0,615, 95% Confidence Interval [CI95%]: 0,52-0,71) and, in 
Bethesda category IV, age lesser than 39,5yrs (sensitivity 37,20%; specificity 79,00%; AUC  
0,63; CI95%: 0,26-0,48) were associated with a malignant diagnosis. 
Surgical complications are listed on table 3. Isolated LwI immediate complications occurred 
in 19 patients; late onset complications during follow-up (keloid scar and hypothyroidism) 
occurred in 38 patients and 3 patients had both immediate and late onset complications 
(hypothyroidism).  A nodular relapse in LwI group was observed in 22 LwI group patients 
(56,41%) out of 39 who, despite a benign diagnosis, were followed in our center. One 
additional patient required TC by benign relapse during follow-up. In LwI group, 40 patients 
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(36,70% ) out of 109 patients developed hypothyroidism, with higher pre-operatory TSH 
value (p=0,011) being associated to a higher post-operatory hypothyroidism risk. No 
malignant thyroid disease relapse was notified in any patient nor death for thyroidal disease. 
 
Discussion 
FTN malignancy rate has been reported to be lesser than 30% [7], however preoperative 
identification and surgical management remain controversial. Globally, we found a higher 
malignancy rate of 45,83%. Excluding incidental microcarcinomas, FNAB III and IV 
categories presented values slightly higher (23,08% and 33,33%  respectively) than those 
predicted according to thyroid cytopathology Bethesda system [7]. Other studies have also 
found higher malignancy frequencies. Baloch ZW et al. found 31% malignancy rate in 122 
patients who underwent thyroid surgery for FTN [6] and Kim ES found a malignancy rate, in 
215 patients, of 47,9% [22]. We verified that incidental microcarcinomas were prevalent 
(25% of patients). Despite papillary microcarcinomas not being an indication to TT, since 
they are indolent and 99% are cured by LwI, rarely their presentation is a metastasis [23]. 
Several malignancy associated risk factors have been described, including younger age, male 
gender, larger nodule size, ultrasonography characteristics and higher tireoglobuline levels 
[24-28]. Nonetheless, this has not being uniformly reported in all studies. In our series, only 
higher TSH values, no thyrotoxicosis, histological multinodularity and, in Bethesda IV, lower 
age were associated with malignancy.  
Spanheimer PM et al. found that 18,81% patients who underwent thyroid LwI required 
completion surgery and that 42,2% required opotheraphy [29], so, in this series, LwI could be 
considered as an inappropriate approach or without functional benefits in 61,01% of patients. 
In our study, TC was required in a high proportion of patients (41,67%), mainly by malignant 
disease in index nodule or as associated lesions. Besides, in LwI group, 35,78% patients 
presented hypothyroidism during follow-up, which corresponds to 23,12% from initial 
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population whose complications were registered. So, we can consider that LwI was 
inappropriate or without functional benefit in 64,79% of patients which may support a more 
extensive approach such as TT. Additionally, we observed a nodular relapse of at least 
20,35% (23/113) during 5 year follow-up period, and if all patients had been followed, a 
higher rate would be expected. In our experience (unpublished data) nodular relapse will 
occur in almost all patients until 30 years after initial diagnosis which could justify follow-up 
for all patients, including those with benign diagnosis. Yet, despite this high rate of nodular 
relapse, most patients will not need TC.  
Rosato et al. followed 14934 patients during 5 years and concluded that LwI is the safest 
thyroidal surgery with a lower morbidity when compared with TT [30]. We found similar 
rates in LwI complications as Rosato, except temporary dysphonia which was higher in our 
series.  Despite LwI being the safest surgical procedure, we found a high TC requirement rate 
and a relatively low morbidity increment. Vaiman et al. verified that, in multinodular goiter, 
complications occurrence rate was higher when LwI were combined with completion surgery 
versus LwI only, but no statistical significant difference in complications occurrence among 
TT and lesser invasive approaches [31]. 
In summary, high rate of malignancy and completion surgery requirement were observed in 
our patients with FTN as long as post-LwI hypothyroidism which made LwI inappropriate or 
without functional benefit in a significant amount of patients. Additionally, LwI is associated 
to a higher economical burden in management the remnant lobe and complications occurrence 
is not different between this approach and TT. We propose total thyroidectomy as the initial 
approach for patients with FTN with preoperative TSH higher than 2,16 mU/L and, in 
Bethesda category IV, less than 39,5yrs. More studies are required to find preoperative 
criteria to identify malignancy on FTN. The increase of preoperative sensitivity, reducing 
second surgery need, depends on the selection of the nodule(s) to be biopsied, expertise of 
cytopathologists and, hopefully, the introduction of new molecular studies in routine clinical 
practice. 
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Table 1 – Pathological diagnosis 
LwI – Main histological diagnosis Index nodule 
Associated 
lesions 
Completion 
thyroidectomy
a 
 n (%) n (%) n/N (%) 
Benign
b 
102 (53,13%) 36 (18,75%) 3/102 (2,94%)
c
 
WDTUMP
d 
2 (1,04%) - 0/2 (0%) 
Malign 88 (45,83%) 41 (21,35%) 77/88 (87,5%) 
Follicular carcinoma 3 (1,56%) - 3/3 (100%) 
Minimally invasive 1   
Widely invasive 0   
Angio-invasive 2   
Hurthle cell follicular carcinoma 3 (1,56%) - 3/3 (100%) 
Minimally invasive 0   
Widely invasive 0   
Angio-invasive 3   
Follicular variant papillary carcinoma  40 (20,83%) 6 (3,125%) 38/40 (95,00%)
e
 
Papillary carcinoma  Hurthle cell 
variant 
27 (14,07%) 3 (1,56%) 27/27 (100%) 
Classic papillary carcinoma 1 (0,52%) 2 (1,04%) 1/1 (100%) 
WDCNOS
f 
1 (0,52%) - 1/1 (100%) 
MicroFVPTC 12 (6,25%) - 4/12 (33,33%) 
Micro PTC Hurthle cells variant 1 (0,52%) - 0/1 (0,00%) 
Papillary microcarcinoma - 30 (15,625%) - 
Normal - 115 (59,90%) - 
a) According to index nodule histological diagnosis. 
b) Benign diagnosis – FA, FA with Hurthle cells, Hurthle cells adenoma, colloid nodule and Hashimoto thyroiditis. 
c) In 2 patients, TC was required by malignant associated lesion.  
d)Well Differentiated Tumor of Uncertain Malignant Potential 
e) One patient who did not underwent TC surgery had a FVPTC with 1,10 cm and associated benign adenomatous nodules.  The other one had a 
solitary FVPTC with 1,00 cm. 
f) Well Differentiated Carcinoma Non Otherwise Specified. 
    
Table 2 – Cytological diagnosis (Bethesda Classification System for thyroid 
cytopathology) 
FNAB 
a 
N (%) Malignancy in histology N(%) 
I 9 (4,79%) - 
II 25 (13,30%) - 
III 26 (13,83%) 9 (34,61%) 
IV 105 (55,85%) 43 (40,95%) 
V 23 (12,23%) - 
Total 188 
b 
 
a) Reclassification based on Bethesda classification system (FNAB I, II and V were included because histological exam revealed a FTN). 
b) In four patients FNAB was unknown. 
  
 
Table 3 - Surgical complications 
LwI complications
a 
TC complications
b 
Permanent RLN
c
 lesion 1 (0,58%) Permanent RLN lesion 1 (1,52%) 
Temporary dysphonia 16 (9,25%) Temporary dysphonia 4 (6,06%) 
Hematoma/Hemorrhage 4 (2,31%) Temporary hypoparathyroidism 2 (3,03%) 
Abscess 1 (0,58%) No 59 (89,39%) 
Hypertrophic or keloid scar 2 (1,16%)   
Hypothyroidism 40 (23,12%)
d
   
No 113 (65,32%)   
a) Unknown in 19 patients. 
b) Unknown in 14 patients. 
c) RLN -  Recurrent Laryngeal Nerve  
d) Isolated hypothyroidism occurred in 36 (20,81%) patients and 4 patients had another associated LwI complication (3 an acute and in 1 a late 
onset complication). 
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Apêndices 
Cristiano Martins Antunes 
Medicine Faculty of University of Porto  
Surgical department of Hospital de São João 
Alameda Professor Hernâni Monteiro,  
4200-319 Porto, Portugal 
Editorial Board, Journal of Surgical Research 
Porto, March 11, 2013 
Dear Sir or Madam  
 
A thyroid cytology presenting a follicular thyroid neoplasm remains a challenge to surgeon decision 
making. First, because it remains impossible to define the character benign versus malignant without 
histological analysis. In the other hand, despite lobectomy with isthmusectomy has potential to be curative, we 
do not know what patients would benefit from a more extensive approach as total thyroidectomy. 
As you shall see, 192 patients submitted to lobectomy with isthmusectomy during three consecutive years 
were studied concerning final histological diagnosis, post-lobectomy hypothyroidism and surgical 
complications occurrence in our center.  
Basically, lobectomy was inappropriate in 41,67% patients who required thyroidectomy completion, 
mainly by a malignant  diagnosis. It was also verified that, in patients submitted to lobectomy, 23,12% had no 
functional benefit because post-surgical hypothyroidism and a nodular relapse in the 5yrs after surgery 
occurred in at least patients 20,35%. Concerning our data, and trough ROC curves, we verified that TSH 
higher than 2,16 mU/L and, in Bethesda category IV, less than 39,5yrs (with a specificity close to 80%) were 
associated with a malignant diagnosis and perhaps these patients would benefit from a total thyroidectomy as 
initial approach. 
The present study was elaborated in my dissertation Master Degree in Medicine by Medicine Faculty 
of University of Porto. There are not any conflicts of interest to report and no entity sponsored this study. 
 
Yours faithfully, with best regards 
 
Cristiano Antunes 
